Search Within

Lee M Krug

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
  3. Book Section (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  2. Center for Molecular Imaging and Biotechnology (12)
  3. Department of Medicine (12)
  4. GSK Faculty (12)
  5. Solid Tumor Oncology Division (11)
  6. Thoracic Oncology (9)

More Groups

People
  1. Mark Kris (6)
  2. Charles Rudin (5)
  3. David Scheinberg (5)
  4. Maria Pietanza (5)
  5. Peter Maslak (4)
  6. Tao Dao (4)

More People

Years
  1. 2016 (3)
  2. 2015 (1)
  3. 2014 (2)
  4. 2011 (1)
  5. 2010 (3)
  6. 2008 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Blood (1)
  3. Cancer Immunology, Immunotherapy (1)
  4. Cancer Research (1)
  5. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (1)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. Elsevier Ireland Ltd. (1)
  6. Springer (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A multi-center, randomized, double-blind phase II study comparing temozolomide (TMZ) plus either veliparib (ABT-888), a PARP inhibitor, or placebo as 2nd or 3rd-line therapy for patients (Pts) with relapsed small cell lung cancers (SCLCs)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Waqar, S. N.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Small cell lung cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?
    Journal Article

    Bunn, P. A. Jr; Minna, J. D.; Augustyn, A.; Gazdar, A. F.; Ouadah, Y.; Krasnow, M. A.; Berns, A.; Brambilla, E.; Rekhtman, N.; Massion, P. P.; more...
    Journal of Thoracic Oncology (2016)

    Fulltext@MSK | Save
  • Small cell and other neuroendocrine tumors of the lung
    Book Section

    Pietanza, M. C.; Krug, L. M.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; Travis, W. D.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed (2015)

    Fulltext@MSK | Save
  • Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Stage IV large cell neuroendocrine carcinoma (LCNEC) of the lung: Clinicopathologic features, treatment, and survival
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Rekhtman, N.; Thomas, S. B.; Sarkaria, I. S.; Rudin, C. M.; Krug, L. M.; Pietanza, M. C.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Journal Article

    Krug, L. M.; Dao, T.; Brown, A. B.; Maslak, P.; Travis, W.; Bekele, S.; Korontsvit, T.; Zakhaleva, V.; Wolchok, J.; Yuan, J.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save
  • Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer
    Journal Article

    Chen, L.; Brown, A. B.; Cheung, I. Y.; Cheung, N. K. V.; Kris, M. G.; Krug, L. M.
    Lung Cancer (2010)

    Fulltext@MSK | Save